Literature DB >> 1433588

Medical management of mild and moderate vesicoureteral reflux: followup studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group.

B S Arant1.   

Abstract

Mild and moderate vesicoureteral reflux is expected to resolve spontaneously in most children treated medically; however, maximum benefit or minimum risk of such therapy has not been defined. A prospective 5-year followup study of infants and children younger than 5 years at entry with primary vesicoureteral reflux (grades I to III/V) and radiographically normal kidneys after the first recognized urinary tract infection was initiated in 1984. A total of 113 patients was entered from 5 centers and 61% of the patients were less than 2 years old. Vesicoureteral reflux was unilateral in 65 cases (58%) and bilateral in 48 (42%). Of the 226 renal units reflux was grade IV in 4 (2%), III in 51 (22%), II in 81 (36%) and I in 25 (11%), and 65 (29%) had no vesicoureteral reflux. Data on 59 patients who have completed the protocol were analyzed for this report. Breakthrough urinary tract infection occurred in 20 patients. Of the 84 ureters with vesicoureteral reflux at diagnosis reflux resolved in 67%, and it was of lower grade in 22%, same grade in 8% and higher grade in 2%. Grade I vesicoureteral reflux resolved in 82%, grade II in 80% and grade III in 46% of the ureters. Resolution was better when vesicoureteral reflux was unilateral left (74%) than unilateral right (46%) or bilateral (60%). Renal scarring occurred, on average, in 10% of the kidneys without known vesicoureteral reflux or exposed only to nondilating (grades I and II) reflux and in 28% of those with dilating (grade III) reflux. Thirteen cases had breakthrough urinary tract infection but only after the scar was noted in 5. We conclude that under good medical management during 5 years of followup, even mild and moderate vesicoureteral reflux can be associated with renal injury.

Entities:  

Mesh:

Year:  1992        PMID: 1433588     DOI: 10.1016/s0022-5347(17)37002-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  [Vesicorenal reflux in childhood].

Authors:  G Zöller; C Radmayr; C Schwentner; C Persson de Geeter; R Stein; R H Ringert
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

4.  Does hydronephrosis predict the presence of severe vesicoureteral reflux?

Authors:  Husam A Abdulnour; Jonathan L Williams; John A Kairalla; Eduardo H Garin
Journal:  Eur J Pediatr       Date:  2012-06-27       Impact factor: 3.183

Review 5.  Primary vesicoureteral reflux; what have we learnt from the recently published randomized, controlled trials?

Authors:  Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2018-08-21       Impact factor: 3.714

6.  Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993.

Authors: 
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

7.  A comparative study of evaluating renal scars by 99mTc-DMSA planar and SPECT renal scans, intravenous urography, and ultrasonography.

Authors:  T C Yen; W P Chen; S L Chang; Y C Huang; C P Hsieh; S H Yeh; C Y Lin
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

8.  How good is technetium-99m mercaptoacetyltriglycine indirect cystography?

Authors:  C De Sadeleer; V De Boe; F Keuppens; B Desprechins; M Verboven; A Piepsz
Journal:  Eur J Nucl Med       Date:  1994-03

9.  Is availability of endoscopy changing initial management of vesicoureteral reflux?

Authors:  Caleb P Nelson; Hillary L Copp; Julie Lai; Christopher S Saigal
Journal:  J Urol       Date:  2009-07-22       Impact factor: 7.450

10.  Has the data efflux regarding the promising outcome following injection of deflux changed the management of adult vesicoureteral reflux?

Authors:  D E Zilberman; Y Mor
Journal:  Adv Urol       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.